Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Genedata Expressionist for MS Gains Increased Adoption in Metabolomics R&D

Published: Tuesday, December 17, 2013
Last Updated: Tuesday, December 17, 2013
Bookmark and Share
Version 8.0 brings new workflows for integrated processing of LC- and GC-MS data on vendor-agnostic platform.

Genedata has announced the release 8.0 of Genedata Expressionist® for Mass Spectrometry, which provides a single platform for the integrated analysis of metabolomics data.

To explore the vast chemical space of the metabolome, researchers use a variety of mass spectrometers, including various LC-MS and GC-MS instruments.

However, consolidating data from different instrument types and manufacturers can pose burdensome challenges. The new Genedata Expressionist for Mass Spectrometry addresses these challenges by combining all data types generated by diverse mass spectrometry instrument parks, and providing workflows for integrated analysis of CE-, IC-, LC- and GC-MS data.

Researchers can capitalize on simultaneous processing, multivariate statistics and sophisticated pathway analyses of unified data sets to achieve a more comprehensive and holistic view of the metabolome.

“The forthcoming challenges are on the side of the poly-omics integration in big meta-metabolomics studies, and the accurate data handling of increasing numbers of samples such as in personalized medicine or global environmental/microbiome metabolomics studies,” said Prof. Dr. Schmitt-Kopplin, director of analytical biochemistry research at the Helmholtz Center Munich.

Using Genedata Expressionist for Mass Spectrometry as a data analysis hub for metabolomics R&D, Prof. Dr. Schmitt-Kopplin noted, “We need algorithms that enable us to efficiently analyze several hundreds of samples in the shortest amount of time while providing high-quality results - and Genedata Expressionist enables all that and more.”

Innovative Algorithms and Interactive Visualization Drive New Insights
In recent years, Genedata Expressionist for Mass Spectrometry has found a rapidly growing user base in leading commercial organizations including pharmaceutical, agrochemical, breeding, and industrial biotechnology companies as well as academia. With interactive visualization tools, innovative peak picking algorithms and the ability to interrogate a large range of natural-substance databases, Genedata Expressionist helps to quickly identify biologically-relevant metabolites. Advanced data management capabilities keep experiment data organized and accessible.

“The ease of use, flexible automation, interactive visualizations and consistent quality of results would all be convincing enough on their own, but, it’s the scalability that really clinches it for us,” said Prof. Lothar Willmitzer, director of molecular physiology at the Max Planck Institute and co-founder of MetaSysX. “Expressionist is the only software solution that can simultaneously process the 1,000s of chromatograms we produce in our large-scale experiments.”

“The latest version of Genedata Expressionist for Mass Spectrometry underscores our commitment to meeting the specific needs of metabolomics research community,” commented Dr. Othmar Pfannes, CEO of Genedata. Our instrument vendor-independent enterprise expertise combined with our continuous investment in innovation will ensure that our customers remain at the cutting-edge of metabolomics research.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genedata Unveils New Japanese Web Site for Expanding Pharma R&D and Life Science Business
New web site closely follows an expansion of Genedata in Japan and supports the growing customer base in Asia.
Monday, November 16, 2009
Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Personalized Medicine
Genedata Phylosopher® and Expressionist® biomarker discovery platforms to be integrated into TcLand Expression’s computational infrastructure.
Thursday, April 09, 2009
Genedata and Roche Extend MS-based Proteomics Biomarker Discovery Collaboration
Collaboration extends three-year license with Roche for the Refiner MS module of the Genedata Expressionist® biomarker discovery system.
Thursday, February 05, 2009
Genedata Signs Agreement with the Fiehn Laboratory at UC Davis for Refiner MS and Analyst Software
The Fiehn Laboratory software platform for mass spectrometry-based metabolomics analyses to classify patient samples and identify biomarkers.
Friday, August 17, 2007
Genedata Expands Collaboration with HepatoSys
Swiss-based computational biology provider Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network.
Friday, February 09, 2007
Genedata Collaborates with HepatoSys Systems Biology Competence Network
Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.
Monday, July 10, 2006
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos